In differentiated thyroid cancer, an incomplete structural response to therapy is associated with significantly worse clinical outcomes than only an incomplete …

F Vaisman, H Tala, R Grewal, RM Tuttle - Thyroid, 2011 - liebertpub.com
Background: We previously demonstrated the clinical utility of using response to therapy
variables obtained during the first 2 years of follow-up to actively modify initial risk estimates …

In Differentiated Thyroid Cancer, an Incomplete Structural Response to Therapy is Associated with Significantly Worse Clinical Outcomes than Only an Incomplete …

F Vaisman, H Tala, R Grewal, RM Tuttle - 2011 - repositorio.udd.cl
Background: We previously demonstrated the clinical utility of using response to therapy
variables obtained during the first 2 years of follow-up to actively modify initial risk estimates …

In differentiated thyroid cancer, an incomplete structural response to therapy is associated with significantly worse clinical outcomes than only an incomplete …

F Vaisman, H Tala, R Grewal… - Thyroid: official journal …, 2011 - pubmed.ncbi.nlm.nih.gov
Background We previously demonstrated the clinical utility of using response to therapy
variables obtained during the first 2 years of follow-up to actively modify initial risk estimates …

In differentiated thyroid cancer, an incomplete structural response to therapy is associated with significantly worse clinical outcomes than only an incomplete …

F Vaisman, H Tala, R Grewal… - Thyroid: Official Journal of …, 2011 - europepmc.org
Background We previously demonstrated the clinical utility of using response to therapy
variables obtained during the first 2 years of follow-up to actively modify initial risk estimates …

In Differentiated Thyroid Cancer, an Incomplete Structural Response to Therapy is Associated with Significantly Worse Clinical Outcomes than Only an Incomplete …

F Vaisman, H Tala, R Grewal, RM Tuttle - 2011 - repositorio.udd.cl
Background: We previously demonstrated the clinical utility of using response to therapy
variables obtained during the first 2 years of follow-up to actively modify initial risk estimates …